Jefferies Financial Group Inc. Apellis Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024
BUY
$55.39 - $72.47 $454,198 - $594,254
8,200 Added 410.0%
10,200 $599,000
Q3 2023

Nov 14, 2023
SELL
$23.65 - $89.22 $3.07 Million - $11.6 Million
-130,000 Reduced 98.48%
2,000 $76,000
Q2 2023

Aug 14, 2023
BUY
$76.68 - $93.31 $153,360 - $186,620
2,000 Added 1.54%
132,000 $12 Million
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $6.06 Million - $8.7 Million
130,000 New
130,000 $8.57 Million

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email